Noninvasive surgery of prostate tissue by high-intensity focused ultrasound

Modern ultrasound transducer material and matching layer technology has permitted us to combine the ultrasound visualization capability with production of high-intensity focused ultrasound (HIFU) on the same ceramic crystal. This development has lead to the design of a transrectal probe for noninvasive surgery of prostate tissue by HIFU. The combined capability using the same ceramic crystal simplifies treatment planning, targeting, and monitoring of tissue before and during the HIFU treatment. This mechanically scanning transrectal probe was introduced for clinical use in 1992 for noninvasive surgery of the prostate to treat benign prostatic hyperplasia (BPH) condition. This paper reviews major steps progressing from conception to the present clinical trial status of the HIFU device. During these clinical studies generation of microbubbles and cavitation were observed. Data from microbubble generation, temperature monitoring in tissue, and autopsy of HIFU-treated animal prostates are presented. Results of human clinical studies are briefly summarized to indicate performance of the device.

[1]  M. Marberger,et al.  Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound. , 1994, The Journal of urology.

[2]  J P Donohue,et al.  High intensity focused ultrasound for the treatment of benign prostatic hyperplasia: early United States clinical experience. , 1994, The Journal of urology.

[3]  K. Hynynen,et al.  Temperature measurements during ultrasound hyperthermia. , 1989, Medical physics.

[4]  Kevin J. Parker,et al.  The thermal pulse decay technique for measuring ultrasonic absorption coefficients , 1983 .

[5]  Richard Bihrle,et al.  Noninvasive surgery of prostate tissue by high-intensity focused ultrasound , 1996 .

[6]  T. Uchida,et al.  Clinical outcome of high-intensity focused ultrasound for treating benign prostatic hyperplasia: preliminary report. , 1998, Urology.

[7]  P. P. Lele,et al.  An analysis of lesion development in the brain and in plastics by high-intensity focused ultrasound at low-megahertz frequencies. , 1972, The Journal of the Acoustical Society of America.

[8]  W J FRY,et al.  Ultrasonically produced localized selective lesions in the central nervous system. , 1955, American journal of physical medicine.

[9]  F. Lizzi,et al.  Therapeutic ultrasound in the treatment of glaucoma. II. Clinical applications. , 1985, Ophthalmology.

[10]  J. Lettvin,et al.  Changes produced in the central nervous system by ultrasound. , 1951, Science.

[11]  M. Marberger,et al.  Tissue ablation in benign prostatic hyperplasia with high-intensity focused ultrasound. , 1994, European urology.

[12]  F. Fry,et al.  Ultrasound intracavity system for imaging, therapy planning and treatment of focal disease , 1992, IEEE 1992 Ultrasonics Symposium Proceedings.

[13]  L. Frizzell,et al.  Threshold dosages for damage to mammalian liver by high intensity focused ultrasound , 1988, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[14]  F. Fry,et al.  Transrectal ablation of prostate tissue using focused ultrasound , 1993 .

[15]  M. Marberger,et al.  Effect of high-intensity focused ultrasound on human prostate cancer in vivo. , 1995, Cancer research.

[16]  J P Donohue,et al.  High-intensity focused ultrasound in the treatment of prostatic tissue. , 1994, Urology.

[17]  A. E. Miller,et al.  A NEW METHOD FOR THE GENERATION AND USE OF FOCUSED ULTRASOUND IN EXPERIMENTAL BIOLOGY , 1942, The Journal of general physiology.